Is stress hyperglycemia ratio associated with poor long-term prognosis and clinical MACE in patients with MINOCA?
Stress hyperglycemia ratio (SHR), with an optimal cut-off of 0.86, may serve as a novel biomarker for cardiovascular risk stratification and predicting long-term MACE in patients with MINOCA.
Our data indicates, for the first time, that SHR is independently associated with poor long-term prognosis in patients suffering from MINOCA. The optimal SHR cut-off value for predicting clinical MACE among MINOCA patients was 0.86. These findings suggest that SHR may play a potential role in the cardiovascular risk stratification of the MINOCA population.
Abdu et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: